The Fucoidan Market size was USD 35.8 million in 2022 and is expected to Reach USD 46.63 million by 2030 and grow at a CAGR of 3.36 % over the forecast period of 2023-2030.
Fucoidan is a substance found in a variety of brown seaweed species. It is also available in capsules, extracts, and powder form. Fucoidan is a type of complex carbohydrate found in brown seaweeds including kombu, wakame, and mozuku. It has been studied for its possible health advantages, which include anti-inflammatory, antioxidant, and immune-boosting qualities.
The fucoidan market has expanded in recent years as demand for natural health supplements and components has increased. Fucoidan is commonly sold as a dietary supplement, frequently in the form of capsules and powders, and is also found in a variety of functional foods and beverages.
KEY DRIVERS
Potential benefits of fucoidan
Cancer and other chronic diseases are major public health concerns, and their global incidence is expected to increase in the coming years. Fucoidan is anti-cancer, anti-inflammatory, and immune-boosting. As a result, fucoidan appears to be a promising natural treatment for a variety of ailments. Fucoidan has been designated as a "Generally Recognized as Safe" food by the Food and Drug Administration (FDA). It does not, however, sell prescription or over-the-counter medications. It is only sold as a supplement outside of meals.
The increasing prevalence of cancer and other chronic diseases.
RESTRAIN
Lack of awareness of the health benefits of fucoidan
Consumers and healthcare professionals alike are still unaware of the health benefits of fucoidan. This may reduce the demand for fucoidan-based products. Many nations, including China, use fucoidan as a traditional medicine, but there is still a large unexplored market for application. Manufacturers' awareness can promote demand for fucoidan in a variety of industries.
OPPORTUNITY
• Increased investment in research and development
Recent anticancer medication research and development initiatives, as well as the synergistic action of fucoidan with chemotherapeutic medicines to kill tumor cells, are expected to drive the worldwide fucoidan market. Furthermore, with increasing applications in cosmetics, fucoidan is still utilized as a complementary therapy in many countries of Asia, including Japan and Korea, where it is frequently suggested to cancer patients. Fucoidan is gaining popularity and use in the Western world as scientific study advances and global regulatory permissions expand. Fucoidan is increasingly being used as a new ingredient in nutritional supplements, cosmetic products, and functional meals and beverages.
Rising applications in various other applications
CHALLENGES
High cost of fucoidan
Fucoidan is a substance found in a variety of brown seaweed species. There are several methods for extracting fucoidan from brown seaweed. The most common are Acid extraction, Alkali extraction, Enzyme extraction, and other methods. The extraction process makes it a relatively expensive ingredient. This could limit its adoption in some applications.
Limited availability of fucoidan
By Type
Powder Type
Capsule Type
Others
By Application
Health Care Products
Pharmaceutical
Cosmetics
By Form Analysis
Based on Form, the market is categorized into Powder Type, Capsule Type, and Others. During the forecast period, the capsule segment is expected to hold a significant proportion of the market. The capsule form has a larger market share since it can be used to make pharmaceuticals and dietary supplements. The capsule is more bioavailable than the other portions. Furthermore, because dietary supplements in capsule form are easier to swallow, various companies are developing them.
Fucoidan powder is used to make a variety of dietary supplements. Liquid forms are utilized to improve product efficacy, particularly in pharmaceuticals and cosmetics, where it guarantees that the product is administered evenly on the skin.
By Application Analysis
Based on application, in 2022, the pharmaceutical sector held a significant proportion of the worldwide fucoidan market. Pharmaceutical businesses are investing in research and development to create medications that are far more effective than previous product versions while also being highly purified and of the finest quality. Fucoidan is used to treat a variety of ailments, including cancer and rheumatoid arthritis.
Fucoidan is used in cosmetics as a thickener, moisturizer, and sunscreen. It is also being studied for its ability to decrease wrinkles and increase skin suppleness.
Asia Pacific has been holding a lion’s share of the fucoidan market in the last few years. Countries like Japan, South Korea, and China were key consumers of fucoidan in the Asia Pacific in 2022. The increasing awareness of the health benefits of fucoidan drives the growth. Traditional Chinese medicine has employed the substance's health advantages for millennia. Rising investment in research and development in the pharmaceutical, and cosmetics industries drive the use of the fucoidan market.
North America is also anticipated to hold a vital share of the global fucoidan market during the forecast period. The U.S. constituted a major share of the market in this region. The growth of the market in North America is being driven by the increasing demand for natural health products, the rising prevalence of chronic diseases, and the growing popularity of seaweed extracts.
Europe's fucoidan market size was USD 121.20 million in 2022 and exhibited a CAGR of 7.5% during the forecast period. This growth is attributed to growing consumer inclination towards Natural products. However, limited seaweed cultivation in the European region may hamper the growth.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Some major key players in the Fucoidan Market are Kamerycah, Yaizu Suisankagaku, Takara, FMC, Seaherb, Fucoidan Force, Marinova, FucoHiq, Haerim Fucoidan, Jeezao, Kanehide, Sigma-Aldrich Corporation, A.M. Todd Botanical Therapeuticals, and Qingdao, and other key players.
In 2023 A U.K.-based firm called OCEANIUM created 'OCEAN ACTIVES Fucoidan,' which cosmetic companies can employ to create various skincare formulations, as high-purity bioactive components.
In 2023 Hepatica made significant investments to create its production system to the requirements set by the European Commission. The organization's production, supply, and storage systems were HACCP-certified.
| Report Attributes | Details |
| Market Size in 2022 | US$ 35.8 Million |
| Market Size by 2030 | US$ 46.63 Million |
| CAGR | CAGR of 3.36 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Powder Type, Capsule Type, Others) • By Application (Health Care Products, Pharmaceuticals, Cosmetics) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Kamerycah, Yaizu Suisankagaku, Takara, FMC, Seaherb, Fucoidan Force, Marinova, FucoHiq, Haerim Fucoidan, Jeezao, Kanehide, Sigma-Aldrich Corporation, A.M. Todd Botanical Therapeuticals, and Qingdao |
| Key Drivers | • Potential benefits of fucoidan • The increasing prevalence of cancer and other chronic diseases. |
| Market Restrain | • Lack of awareness of the health benefits of fucoidan |
Ans: Fucoidan Market is anticipated to expand by 3.36 % from 2023 to 2030.
Ans: Drivers are potential benefits of fucoidan and the increasing prevalence of cancer and other chronic diseases.
Ans: USD 46.63 million is expected to grow by 2030.
Ans: The Asia Pacific region dominated the Fucoidan market.
Ans: The high cost of fucoidan and limited availability are challenges that hinder the growth of the fucoidan market.
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1. Introduction
4.1.1 Impact on Major Economies
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Germany
4.1.1.4 France
4.1.1.5 United Kingdom
4.1.1.6 China
4.1.1.7 Japan
4.1.1.8 South Korea
4.1.1.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Fucoidan Market Segmentation, By Type
8.1 Powder Type
8.2 Capsule Type
8.3 Others
9. Fucoidan Market Segmentation, By Application
9.1 Health Care Products
9.2 Pharmaceutical
9.3 Cosmetics
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Fucoidan Market by Country
10.2.2 North America Fucoidan Market by Type
10.2.3 North America Fucoidan Market by Application
10.2.4 USA
10.2.4.1 USA Fucoidan Market by Type
10.2.4.2 USA Fucoidan Market by Application
10.2.5 Canada
10.2.5.1 Canada Fucoidan Market by Type
10.2.5.2 Canada Fucoidan Market by Application
10.2.6 Mexico
10.2.6.1 Mexico Fucoidan Market by Type
10.2.6.2 Mexico Fucoidan Market by Application
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Fucoidan Market by Country
10.3.1.2 Eastern Europe Fucoidan Market by Type
10.3.1.3 Eastern Europe Fucoidan Market by Application
10.3.1.4 Poland
10.3.1.4.1 Poland Fucoidan Market by Type
10.3.1.4.2 Poland Fucoidan Market by Application
10.3.1.5 Romania
10.3.1.5.1 Romania Fucoidan Market by Type
10.3.1.5.2 Romania Fucoidan Market by Application
10.3.1.6 Hungary
10.3.1.6.1 Hungary Fucoidan Market by Type
10.3.1.6.2 Hungary Fucoidan Market by Application
10.3.1.7 Turkey
10.3.1.7.1 Turkey Fucoidan Market by Type
10.3.1.7.2 Turkey Fucoidan Market by Application
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Fucoidan Market by Type
10.3.1.8.2 Rest of Eastern Europe Fucoidan Market by Application
10.3.2 Western Europe
10.3.2.1 Western Europe Fucoidan Market by Country
10.3.2.2 Western Europe Fucoidan Market by Type
10.3.2.3 Western Europe Fucoidan Market by Application
10.3.2.4 Germany
10.3.2.4.1 Germany Fucoidan Market by Type
10.3.2.4.2 Germany Fucoidan Market by Application
10.3.2.5 France
10.3.2.5.1 France Fucoidan Market by Type
10.3.2.5.2 France Fucoidan Market by Application
10.3.2.6 UK
10.3.2.6.1 UK Fucoidan Market by Type
10.3.2.6.2 UK Fucoidan Market by Application
10.3.2.7 Italy
10.3.2.7.1 Italy Fucoidan Market by Type
10.3.2.7.2 Italy Fucoidan Market by Application
10.3.2.8 Spain
10.3.2.8.1 Spain Fucoidan Market by Type
10.3.2.8.2 Spain Fucoidan Market by Application
10.3.2.9 Netherlands
10.3.2.9.1 Netherlands Fucoidan Market by Type
10.3.2.9.2 Netherlands Fucoidan Market by Application
10.3.2.10 Switzerland
10.3.2.10.1 Switzerland Fucoidan Market by Type
10.3.2.10.2 Switzerland Fucoidan Market by Application
10.3.2.11 Austria
10.3.2.11.1 Austria Fucoidan Market by Type
10.3.2.11.2 Austria Fucoidan Market by Application
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Fucoidan Market by Type
10.3.2.12.2 Rest of Western Europe Fucoidan Market by Application
10.4 Asia-Pacific
10.4.1 Asia Pacific Fucoidan Market by Country
10.4.2 Asia Pacific Fucoidan Market by Type
10.4.3 Asia Pacific Fucoidan Market by Application
10.4.4 China
10.4.4.1 China Fucoidan Market by Type
10.4.4.2 China Fucoidan Market by Application
10.4.5 India
10.4.5.1 India Fucoidan Market by Type
10.4.5.2 India Fucoidan Market by Application
10.4.6 Japan
10.4.6.1 Japan Fucoidan Market by Type
10.4.6.2 Japan Fucoidan Market by Application
10.4.7 South Korea
10.4.7.1 South Korea Fucoidan Market by Type
10.4.7.2 South Korea Fucoidan Market by Application
10.4.8 Vietnam
10.4.8.1 Vietnam Fucoidan Market by Type
10.4.8.2 Vietnam Fucoidan Market by Application
10.4.9 Singapore
10.4.9.1 Singapore Fucoidan Market by Type
10.4.9.2 Singapore Fucoidan Market by Application
10.4.10 Australia
10.4.10.1 Australia Fucoidan Market by Type
10.4.10.2 Australia Fucoidan Market by Application
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Fucoidan Market by Type
10.4.11.2 Rest of Asia-Pacific Fucoidan Market by Application
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Fucoidan Market by Country
10.5.1.2 Middle East Fucoidan Market by Type
10.5.1.3 Middle East Fucoidan Market by Application
10.5.1.4 UAE
10.5.1.4.1 UAE Fucoidan Market by Type
10.5.1.4.2 UAE Fucoidan Market by Application
10.5.1.5 Egypt
10.5.1.5.1 Egypt Fucoidan Market by Type
10.5.1.5.2 Egypt Fucoidan Market by Application
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Fucoidan Market by Type
10.5.1.6.2 Saudi Arabia Fucoidan Market by Application
10.5.1.7 Qatar
10.5.1.7.1 Qatar Fucoidan Market by Type
10.5.1.7.2 Qatar Fucoidan Market by Application
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Fucoidan Market by Type
10.5.1.8.2 Rest of Middle East Fucoidan Market by Application
10.5.2 Africa
10.5.2.1 Africa Fucoidan Market by Country
10.5.2.2 Africa Fucoidan Market by Type
10.5.2.3 Africa Fucoidan Market by Application
10.5.2.4 Nigeria
10.5.2.4.1 Nigeria Fucoidan Market by Type
10.5.2.4.2 Nigeria Fucoidan Market by Application
10.5.2.5 South Africa
10.5.2.5.1 South Africa Fucoidan Market by Type
10.5.2.5.2 South Africa Fucoidan Market by Application
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Fucoidan Market by Type
10.5.2.6.2 Rest of Africa Fucoidan Market by Application
10.6 Latin America
10.6.1 Latin America Fucoidan Market by Country
10.6.2 Latin America Fucoidan Market by Type
10.6.3 Latin America Fucoidan Market by Application
10.6.4 Brazil
10.6.4.1 Brazil Fucoidan Market by Type
10.6.4.2 Brazil Fucoidan Market by Application
10.6.5 Argentina
10.6.5.1 Argentina Fucoidan Market by Type
10.6.5.2 Argentina Fucoidan Market by Application
10.6.6 Colombia
10.6.6.1 Colombia Fucoidan Market by Type
10.6.6.2 Colombia Fucoidan Market by Application
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Fucoidan Market by Type
10.6.7.2 Rest of Latin America Fucoidan Market by Application
11. Company Profile
11.1 Kamerycah
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Yaizu Suisankagaku
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Takara
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 FMC
11.4 Company Overview
11.4.2 Financials
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Seaherb
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Fucoidan Force
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 Marinova
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 FucoHiq
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Haerim Fucoidan
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Sigma-Aldrich Corporation
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
11.11 A.M. Todd Botanical Therapeuticals
11.11.1 Company Overview
11.11.2 Financials
11.11.3 Product/Services Offered
11.11.4 SWOT Analysis
11.11.5 The SNS View
11.12 Kanehide
11.12.1 Company Overview
11.12.2 Financials
11.12.3 Product/Services Offered
11.12.4 SWOT Analysis
11.12.5 The SNS View
11.13 Jeezao
11.13.1 Company Overview
11.13.2 Financials
11.13.3 Product/Services Offered
11.13.4 SWOT Analysis
11.13.5 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Food Emulsifiers Market size was USD 3.49 billion in 2022 and is expected to Reach USD 5.07 billion by 2030 and grow at a CAGR of 4.8 % over the forecast period of 2023-2030.
Black Pepper Market Size was esteemed at USD 2.63 billion out of 2022 and is supposed to arrive at USD 3.55 billion by 2030, and develop at a CAGR of 3.82% over the forecast period 2023-2030.
Brain Health Supplements Market Report Scope & Overview: The Brain Health Supplements Market Size
Bottled Water Market Report Scope & Overview: Bottled Water Market Size was valued at USD 299 bil
CBD Gummies Market Report Scope & Overview: The CBD Gummies Market Size was esteemed at USD 2.52
The Ready-to-Drink Beverages Market size was USD 710.56 billion in 2022 and is expected to Reach USD 1149.7 billion by 2030 and grow at a CAGR of 6.2 % over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
